Compile Data Set for Download or QSAR
Report error Found 35 Enz. Inhib. hit(s) with Target = 'Interleukin-21'
TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649500(US11891386, Compound ARI-120)
Affinity DataIC50: 0.300nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649497(US11891386, Compound ARI-083)
Affinity DataIC50: 0.300nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649499(US11891386, Compound ARI-118)
Affinity DataIC50: 0.800nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649495(US11891386, Compound ARI-056)
Affinity DataIC50: 4.90nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649503(US11891386, Compound ARI-148)
Affinity DataIC50: 5.90nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649487(US11891386, Compound ARI-067)
Affinity DataIC50: 6.30nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649498(US11891386, Compound ARI-090)
Affinity DataIC50: 8.40nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649489(US11891386, Compound ARI-140)
Affinity DataIC50: 8.60nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649505(US11891386, Compound ARI-049)
Affinity DataIC50: 10.1nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649502(US11891386, Compound ARI-146)
Affinity DataIC50: 13.4nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649506(US11891386, Compound ARI-065)
Affinity DataIC50: 14nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649491(US11891386, Compound ARI-143)
Affinity DataIC50: 18.8nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649488(US11891386, Compound ARI-087)
Affinity DataIC50: 25.4nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649492(US11891386, Compound ARI-149)
Affinity DataIC50: 30.3nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM50506039(CHEMBL1324296 | US11891386, Compound 002)
Affinity DataIC50: 31.8nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM50506039(CHEMBL1324296 | US11891386, Compound 002)
Affinity DataIC50: 38.2nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649493(US11891386, Compound ARI-030)
Affinity DataIC50: 40nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649494(US11891386, Compound ARI-031)
Affinity DataIC50: 42.6nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649501(US11891386, Compound ARI-145)
Affinity DataIC50: 46.9nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649485(US11891386, Compound ARI-066)
Affinity DataIC50: 48.6nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649482(US11891386, Compound ARI-055)
Affinity DataIC50: 73.6nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649496(US11891386, Compound ARI-060)
Affinity DataIC50: 110nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM649490(US11891386, Compound ARI-142)
Affinity DataIC50: 209nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM50605060(CHEMBL5198290 | US11891386, Compound 004)
Affinity DataIC50: 231nMAssay Description:IL-21 levels in cell supernatants and cell-free control samples were measured using the ALPHALISA assay kit from Perkin Elmer, following the manufact...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM247023(US9701663, 6)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM247026(US9701663, 7)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM247027(US9701663, 8)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM247010(1-((1-(phenylsulfonyl)piperidin-4-yl)methyl)-5-(1H...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM247028(1-((5,5-dimethyl-1-(phenylsulfonyl)pyrrolidin-3-yl...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM247029(1-((1-(4-chlorophenylsulfonyl)piperidin-4-yl)methy...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM247030(5-(1H-pyrazol-4-yl)-1-((1-(pyridin-3-ylsulfonyl)pi...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM247031(1-((1-(2-fluorophenylsulfonyl)piperidin-4-yl)methy...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM247032(rac.-cis-1-((-5-methyl-1-(phenylsulfonyl)pyrrolidi...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM247033(rac.-trans-1-((-5-methyl-1-(phenylsulfonyl)pyrroli...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-21(Human)
Ariagen

US Patent
LigandPNGBDBM247034(1-((1-(methylsulfonyl)piperidin-4-yl)methyl)-5-(1H...)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In DepthDetails
US Patent